@averagepenny.bsky.social

4 days ago

#NDRA ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value

www.businesswire.com/news/home/20...

StockTitan

@stocktitan.net

4 days ago

ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value ENDRA Life Sciences (Nasdaq: NDRA) said its Board of Directors has launched a formal review of strategic alternatives to maximize shareholder value, including possible investments, mergers, collaborations, asset sales, or a sale of the company.The Board engaged Lucid Capital Management as financial advisor and K&L Gates as legal counsel and said operations will continue while no timetable has been set for completion.

#NDRA ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value

www.stocktitan.net/news/NDRA/endra-life-sci...

@averagepenny.bsky.social

1 week ago

Stocks Under $10 to Watch in 2026: IBRX, VTIX, NDRA, SMX — Emerging Themes Across Biotech, XR, Diagnostics, and AI Supply Chains Getting your Trinity Audio player ready... As capital rotation intensifies across micro- and small-cap equities in 2026, a new wave of sub-$10 stocks is gaining traction among investors seeking exposu...

Stocks Under $10 to Watch in 2026: #IBRX, #VTIX, #NDRA, #SMX — Emerging Themes Across Biotech, XR, Diagnostics, and AI Supply Chains

thestreetreports.com/stocks-under...

Giants67

@giants1967.bsky.social

1 week ago

ENDRA Life Sciences (NASDAQ: NDRA): Medical Diagnostic Play in the $100B+MASH+GLP Healthcare Boom Getting your Trinity Audio player ready... While investors chase the obvious opportunity in the emerging MASH drug market, another potentially powerful theme is developing just beneath the surface. Di...

#NDRA ENDRA Life Sciences (NASDAQ: NDRA): Medical Diagnostic Play in the $100B+MASH+GLP Healthcare Boom
thestreetreports.com/endra-life-s...

@averagepenny.bsky.social

2 weeks ago

$SNYR Breaking into 1,600 Kroger - Pennystocks Captain Pennys Open House Pennystocks Captain Pennys Open House: $SNYR Breaking into 1,600 Kroger Stores! https://www.youtube.com/watch?v=rEm1g-NjABM

Stocks In The Spotlight Recently: #VTIX #PRSO #NDRA #MMCP #AMLM #CBDW

investorshangout.com/post/view?id...

@averagepenny.bsky.social

2 weeks ago

Medical Technology Alert: BSX, TFX, ARAY, CSDX, NDRA Emerging Across Cancer Treatment and GLP-1 Healthcare Ecosystems Getting your Trinity Audio player ready... The global absorbable hydrogel tissue spacer market, used primarily in prostate cancer radiation therapy, is gaining momentum as healthcare providers increas...

Medical Alert #BSX, #TFX, #ARAY, #CSDX, #NDRA Highlight Growing Hydrogel Tissue Spacer Market in Radiation Oncology

thestreetreports.com/medical-aler...

@averagepenny.bsky.social

3 weeks ago

ENDRA Life Sciences (NASDAQ: NDRA): Massive MASH and GLP-1 Healthcare Boom Offering Tremendous Opportunity Now! Getting your Trinity Audio player ready... As pharmaceutical companies race to develop treatments for metabolic dysfunction–associated steatohepatitis (MASH) and related steatotic liver disease (SLD),...

#NDRA ENDRA Life Sciences (NASDAQ: NDRA): Massive MASH and GLP-1 Healthcare Boom Offering Tremendous Opportunity Now!

thestreetreports.com/endra-life-s...

Giants67

@giants1967.bsky.social

3 weeks ago

Spotlight 2026 Press Releases, - Pennystocks Captain Pennys Open House Pennystocks Captain Pennys Open House: Spotlight 2026 Press Releases, Coverage, Earnings, Podcasts $VTIX Virtuix Reports Third Quarter

Spotlight 2026 Press Releases, Coverage, Earnings, Podcasts
investorshangout.com/post/view?id...
#VTIX #PRSO #MOBX #NDRA #SNYR #TOON

@averagepenny.bsky.social

3 weeks ago

Spotlight Stocks In The News 2/27 - Pennystocks Captain Pennys Open House Pennystocks Captain Pennys Open House: Spotlight Stocks In The News 2/27 $OGN Organons Breast Cancer Treatment Poherdy Receives Positi

Stocks In The News: #OGN #NDRA #TOON #RDZN #FAGI #SNYR

investorshangout.com/post/view?id...

Giants67

@giants1967.bsky.social

3 weeks ago

Spotlight Stocks In The News 2/27 - Pennystocks Captain Pennys Open House Pennystocks Captain Pennys Open House: Spotlight Stocks In The News 2/27 $OGN Organons Breast Cancer Treatment Poherdy Receives Positi

Spotlight Stocks In The News
investorshangout.com/post/view?id...
#OGN #SNYR #RDZN #NDRA #TOON #FAGI

@averagepenny.bsky.social

1 month ago

#NDRA ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care

www.businesswire.com/news/home/20...

StockTitan

@stocktitan.net

1 month ago

Device targets MRI-like liver fat tests for 2B MASLD patients Study of 56 scans finds 0.89 ICC and 3.3% SEM, suggesting consistent liver fat readings for MASLD, which affects about 30% of adults worldwide.

#NDRA ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care

www.stocktitan.net/news/NDRA/endra-s-taeus-...

Giants67

@giants1967.bsky.social

1 month ago

ENDRA Life Sciences (NASDAQ: NDRA): A Dual-Engine Growth Story Alongside KNRX, BATL, TALK, DNN, VZLA in Focus Getting your Trinity Audio player ready... In a market searching for asymmetric upside, ENDRA Life Sciences (NASDAQ: NDRA) is quietly building one of the more compelling dual-engine growth narratives ...

#NDRA ENDRA Life Sciences (NASDAQ: NDRA): A Dual-Engine Growth Story Alongside #KNRX, #BATL, #TALK, #DNN, #VZLA in Focus
thestreetreports.com/endra-life-s...

@averagepenny.bsky.social

1 month ago

5 Stocks Under $5 to Watch Now: OBAI, NDRA, RIME, VTIX, OPEN AI Stocks | Nasdaq Stocks Under $5 | Small-Cap Growth | Breakout Stocks 2026 As investors search for stocks under $5 with breakout potential in 2026, several Nasdaq-listed small-cap companies are gain...

5 Stocks Under $5 to Watch Now: #OBAI, #NDRA, #RIME, #VTIX, #OPEN

www.barchart.com/story/news/2...

Giants67

@giants1967.bsky.social

2 months ago

ENDRA Life Sciences (NASDAQ: NDRA) Gaining Attention as HYPE Token Surges 50% See Why Now! Getting your Trinity Audio player ready... As markets increasingly blur the line between traditional finance and digital assets, ENDRA Life Sciences (NASDAQ: NDRA) is emerging as a unique small-cap st...

#NDRA ENDRA Life Sciences (NASDAQ: NDRA) Gaining Attention as HYPE Token Surges 50% See Why Now!
thestreetreports.com/endra-life-s...

@averagepenny.bsky.social

2 months ago

MAGA SmallCaps Watchlist: ROLR, SURG, IBRX, BNAI, NDRA - January 2026 Focus As capital rotates toward select U.S.-based innovation stories heading into early 2026, a group of small-cap names across regulated fintech, wireless infrastructure, immuno-oncology, and medical...

MAGA SmallCaps Watchlist: #ROLR, #SURG, #IBRX, #BNAI, #NDRA - January 2026 Focus

www.marketscreener.com/news/maga-sm...

Grumpy10

@grumpy10.bsky.social

2 months ago

MAGA SmallCaps Watchlist: ROLR, SURG, IBRX, NDRA — January 2026 Focus Getting your Trinity Audio player ready... As capital rotates toward select U.S.-based innovation stories heading into early 2026, a group of small-cap names across regulated fintech, wireless infrast...

2026 Focus Small Caps
thestreetreports.com/maga-smallca...
#SURG #ROLR #NDRA #IBRX

Small Cap Strategist

@smcapstrategist.bsky.social

3 months ago

Small-cap stocks with strong volume declines, Thu Dec 4th - #YB #NA #MAMO #LASE #DRMA #CNTX #SYBX #SVCO #PLRX #NDRA #KITT #EKSO #CBIO #BBNX #ZKH #NOAH #GCO #ECVT #BBW - More: crystalequityresearch.com/leading-indi... - #smallcap

StockTitan

@stocktitan.net

3 months ago

#NDRA ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use

www.stocktitan.net/news/NDRA/endra-s-taeus-...

StockTitan

@stocktitan.net

4 months ago

#NDRA ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker

www.stocktitan.net/news/NDRA/endra-feasibil...

Grumpy10

@grumpy10.bsky.social

4 months ago

The New Era of Treasury Strategy: ENDRA Life Sciences (NASDAQ: NDRA) Impacting Healthcare ENDRA Life Sciences (NASDAQ: NDRA), a pioneer in next-generation medical imaging for the early detection and monitoring of liver disease, is redefining strategic finance for public companies through a...

#NDRA ENDRA Life Sciences A New Approach to Treasury Management Designed for Long-Term Growth
www.barchart.com/story/news/3...

StockTitan

@stocktitan.net

4 months ago

#NDRA ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results

www.stocktitan.net/news/NDRA/endra-life-sci...

Grumpy10

@grumpy10.bsky.social

4 months ago

ENDRA Life Sciences Inc. (NASDAQ: NDRA) Digital Asset Tokenization to Drive Long-Term Shareholder Value Getting your Trinity Audio player ready... ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer in medical imaging and digital innovation, is redefining the intersection of healthcare technology and dec...

#NDRA ENDRA Life Sciences Inc. a redefining the intersection of healthcare technology and decentralized finance
thestreetreports.com/endra-life-s...

Giants67

@giants1967.bsky.social

4 months ago

#NDRA ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings
www.businesswire.com/news/home/20...

Grumpy10

@grumpy10.bsky.social

4 months ago

#NDRA ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings
www.businesswire.com/news/home/20...
#medicalinnovation

StockTitan

@stocktitan.net

4 months ago

#NDRA ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA

www.stocktitan.net/news/NDRA/endra-life-sci...

StockTitan

@stocktitan.net

5 months ago

ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings ENDRA Life Sciences (Nasdaq: NDRA) closed a private placement financing that generated gross proceeds of approximately $4.9 million with potential for up to an additional $9.5 million from warrant exercises. Concurrently, the company launched a digital asset treasury strategy and acquired 78,863.1 HYPE tokens, valued at approximately $3.0 million as of October 21, 2025.The DAT strategy targets long-term token exposure plus active yield techniques (options overlays, staking, DeFi participation) with trade‑ and portfolio‑level risk controls, aiming to grow tokens‑per‑share, generate reinvestable income, and create optionality for crypto‑related M&A and capital activities. Lucid Capital Markets acted as sole placement agent.

#NDRA ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings

www.stocktitan.net/news/NDRA/endra-life-sci...

StockTitan

@stocktitan.net

5 months ago

ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca ENDRA Life Sciences (Nasdaq: NDRA) announced $4.9 million in committed proceeds from an at-market private placement to fund a new digital asset treasury (DAT) strategy managed with Arca, and intends to appoint Arca CIO Jeff Dorman to its Digital Asset Advisory Board.The purchase agreement covers 744,340 shares (or pre-funded warrants) and accompanying warrants to buy up to 1,488,680 shares, sold at a combined price of $6.57. Warrants are exercisable immediately at $6.32 and expire in five years; pre-funded warrants carry a $0.0001 exercise price. If all warrants are exercised, gross proceeds could reach $14.4 million. Majority of net proceeds will go to DAT operations and crypto accumulation; remaining proceeds to complete the TAEUS pilot validation imaging study for MASLD/MASH.

#NDRA ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca

www.stocktitan.net/news/NDRA/endra-life-sci...

StockTitan

@stocktitan.net

7 months ago

ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results ENDRA Life Sciences (NASDAQ: NDRA), developer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), reported Q2 2025 financial results and provided key business updates. The company has made significant progress in its TAEUS Liver system development, with initial testing showing major accuracy improvements against MRI-PDFF measurements.ENDRA plans to conduct a 250-subject multisite clinical trial for FDA De Novo submission by year-end. The company has expanded its patent portfolio to 85 issued patents globally and implemented substantial cost reductions, resulting in a 42% decrease in Q2 operating expenses to $1.2 million. Cash position stands at $1.8 million as of June 30, 2025, with quarterly cash burn reduced to $1.1 million.

#NDRA ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results

www.stocktitan.net/news/NDRA/endra-life-sci...